About medartis holding ag - MDRSF
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
MDRSF At a Glance
Medartis Holding AG
Hochbergerstrasse 60E
Basel, Basel-Stadt (Basle Town) 4057
| Phone | 41-61-633-34-34 | Revenue | 255.30M | |
| Industry | Medical Specialties | Net Income | 4.01M | |
| Sector | Health Technology | 2024 Sales Growth | 8.215% | |
| Fiscal Year-end | 12 / 2025 | Employees | 949 | |
| View SEC Filings |
MDRSF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 192.942 |
| Price to Sales Ratio | 3.035 |
| Price to Book Ratio | 2.602 |
| Price to Cash Flow Ratio | 24.22 |
| Enterprise Value to EBITDA | 18.885 |
| Enterprise Value to Sales | 2.96 |
| Total Debt to Enterprise Value | 0.177 |
MDRSF Efficiency
| Revenue/Employee | 269,015.917 |
| Income Per Employee | 4,221.34 |
| Receivables Turnover | 4.934 |
| Total Asset Turnover | 0.553 |
MDRSF Liquidity
| Current Ratio | 5.213 |
| Quick Ratio | 3.661 |
| Cash Ratio | 2.718 |
MDRSF Profitability
| Gross Margin | 71.872 |
| Operating Margin | 5.754 |
| Pretax Margin | 0.828 |
| Net Margin | 1.569 |
| Return on Assets | 0.868 |
| Return on Equity | 1.334 |
| Return on Total Capital | 0.929 |
| Return on Invested Capital | 1.044 |
MDRSF Capital Structure
| Total Debt to Total Equity | 44.958 |
| Total Debt to Total Capital | 31.014 |
| Total Debt to Total Assets | 26.356 |
| Long-Term Debt to Equity | 42.071 |
| Long-Term Debt to Total Capital | 29.023 |